To view other meetings from ZDA1 choose calendar year:
| Study Section | Panel Name | Meeting Rosters |
|---|---|---|
| ZDA1 SKP-D(16) | MECHANISM FOR TIME-SENSITIVE DRUG ABUSE RESEARCH (R21 CLINICAL TRIAL OPTIONAL) | 04/14/21 |
| ZDA1 SXC-G(01) | ELUCIDATION OF MECHANISMS UNDERLYING COMPLEX MORBIDITIES OF SUD AND OTHER MENTAL ILLNESSES IN PEOPLE LIVING WITH HIV/AIDS (R01 CLINICAL TRIAL OPTIONAL) | 04/07/21 |
| ZDA1 PXN-F(13) | NIDA R13 CONFERENCE GRANT REVIEW | 04/01/21 |
| ZDA1 SKP-D(08) | IMPLEMENTING THE HIV SERVICE CASCADE FOR JUSTICE-INVOLVED POPULATIONS (U01 - CLINICAL TRIAL OPTIONAL) | 03/30/21 |
| ZDA1 PXN-F(15) | NIDA-L CONFLICT SEP | 03/25/21 |
| ZDA1 YXF-U(10) | MULTI-SITE STUDIES FOR SYSTEM-LEVEL IMPLEMENTATION OF SUBSTANCE USE PREVENTION AND TREATMENT SERVICES (R01; R34) | 03/22/21 |
| ZDA1 IXN-O(02) | AVENIR AWARD PROGRAM FOR GENETICS OR EPIGENETICS OF SUBSTANCE USE DISORDERS (DP1 CLINICAL TRIAL OPTIONAL) | 03/11/21 |
| ZDA1 YXF-U(05) | INTERVENTIONS TO PREVENT ELECTRONIC NICOTINE DELIVERY SYSTEMS (ENDS) USE AMONG ADOLESCENTS (R01 - CLINICAL TRIAL OPTIONAL) | 03/10/21 |
| ZDA1 GXM-A(07) | USING HUMAN CELL ANIMAL CHIMERA BRAINS TO STUDY HIV LATENCY AND PATHOLOGY R01 - CLINICAL TRIALS NOT ALLOWED | 03/10/21 |
| ZDA1 GXM-A(06) | ADVANCING HIV/AIDS RESEARCH THROUGH COMPUTATIONAL NEUROSCIENCE FOA (R01 - CLINICAL TRIAL OPTIONAL) | 03/03/21 |
| ZDA1 SKM-D(04) | NIDA CAREER DEVELOPMENT AND EDUCATION SEP (K99/R00 AND R25) | 03/01/21 |
| ZDA1 IXN-O(12) | DEVICE-BASED TREATMENTS FOR SUBSTANCE USE DISORDERS (UG3/UH3, CLINICAL TRIAL OPTIONAL) | 02/26/21 |
| ZDA1 IXR-Q(01) | NIDA CENTERS REVIEW | 02/26/21 |
| ZDA1 SXC-G(11) | EXPLORING EPIGENOMIC OR NON-CODING RNA REGULATION IN THE DEVELOPMENT, MAINTENANCE, OR TREATMENT OF CHRONIC PAIN (R61/R33 CLINICAL TRIAL OPTIONAL) | 02/22/21 |
| ZDA1 IXR-Q(14) | EXPLOITING GENOME OR EPIGENOME EDITING TO FUNCTIONALLY VALIDATE GENES OR VARIANTS INVOLVED IN SUBSTANCE USE DISORDERS (R21/R33 CLINICAL TRIAL NOT ALLOWED) | 02/18/21 |
| ZDA1 GXM-A(03) | BRAIN INITIATIVE: TOOLS FOR GERMLINE GENE EDITING IN MARMOSETS (U01 - CLINICAL TRIAL NOT ALLOWED) | 02/17/21 |
| ZDA1 SKP-D(31) | PHASE II (TOPIC 166) LEVERAGING HEALTH IT SOLUTIONS TO COMBAT OPIOID MISUSE | 02/12/21 |
| ZDA1 TXT-V(09) | PREP FOR HIV PREVENTION AMONG SUBSTANCE USING POPULATIONS (R01 - CLINICAL TRIAL OPTIONAL) | 02/11/21 |